In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

The IRS issued two sets of proposed regulations for Trump accounts, the new type of individual retirement accounts for eligible children under Sec. 530A of H.R. 1, P.L. 119‑21, known as the One Big ...

BOISE, Idaho — Citing a need to "improve our structures" and "better deliver on our mission," Boise State University has announced dramatic changes coming to the academic department. In a letter to ...

New NASA Administrator Jared Isaacman announced a major overhaul of the agency's Artemis moon program Friday, acknowledging that the agency's plan to land astronauts on the moon in 2028 was not ...

A mock-up of the European New Generation Fighter for the Future Combat Air System is pictured at the Paris Air Show, June 18, 2023. (Julien de Rosa/AFP via Getty Images) PARIS — Airbus is open to a ...

Vanderbilt basketball has surpassed its 2024-25 win total with a few weeks left to go in the season and has done it while demonstrating what an extra year of Mark Byington's tenure can do for it.

This blog post explains the cross-NUMA memory access issue that occurs when you run llama.cpp in Neoverse. It also introduces a proof-of-concept patch that addresses this issue and can provide up to a ...

Mayor Mamdani on Thursday took the first step toward getting New York City’s planned universal child care for 2-year-olds off the ground, asking providers if they’re interested in offering the new ...

The Two Rivers community garden program has seen high demand for the 2026 growing season. Nearly all of the 115 garden plots were claimed shortly after applications opened in mid-January. Each 3-by-20 ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse event reports; bitopertin delayed two weeks amid efficacy and ...